ACEON® is indicated in patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction. ACEON® can be used with conventional treatment for management of coronary artery disease, such as antiplatelet, antihypertensive or lipid-lowering therapy. 2
ACEON® is contraindicated in patients known to be hypersensitive to this product or to any other ACE inhibitor, and in patients with a history of angioedema related to previous treatment with an ACE inhibitor.2
In patients with stable coronary artery disease, ACEON® should be given at an initial dose of 4 mg once daily for 2 weeks, and then increased as tolerated, to a maintenance dose of 8 mg once daily. In elderly patients (>70 yrs), ACEON® should be given as a 2 mg dose once daily in the first week, followed by 4 mg once daily in the second week and 8 mg once daily for maintenance dose if tolerated. 2
